Lexaria Bioscience CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Lexaria Bioscience Corp. announced its 2026 Annual Meeting of Shareholders to be held on January 27, 2026, to vote on director elections, auditor ratification, and director acts.
NASDAQ
Lexaria Bioscience Corp. has scheduled its 2025 annual shareholder meeting for January 14, 2025, to vote on key proposals including the election of directors, ratification of auditors, executive compensation, and a warrant exercise proposal.
NASDAQ
Lexaria Bioscience Corp. will hold its annual shareholder meeting on April 23, 2024, to elect directors, ratify the appointment of auditors, and approve acts of the directors.